EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor

Jillian G Baker, Victor Jun Yu Lim, Richard G W Proudman, Franziska N Z Giese, Peter Kolb

Molecular Pharmacology · 2025

DOI: 10.1016/j.molpha.2025.100081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Jillian G Baker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cell Signalling, School of Life Sciences, C Floor Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Respiratory Medic…. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-1, Adrenergic beta-1 Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β1-adrenoceptor exists in at least 2 agonist-stabilized conformational ensembles: a "catecholamine" ensemble induced via the intrahelical binding site through which catecholamines and most agonists act and a "secondary" ensemble of conformations through which CGP12177 stimulates agonist responses. Several β-ligands stimulate agonist responses through both conformations, resulting in biphasic concentration responses, but little is known about the structure-activity relationship of such ligands. Using a structure-activity hypothesis built on the predicted poses CGP12177 and 3 biphasic agonists (alprenolol, oxprenolol, and bucindolol), predictions based on ligand similarity and structural compatibility reasoning were made about 11 other β1-ligands not yet tested for secondary conformation interaction and examined in radioligand binding and functional assays using human β1- and β2-adrenoceptors. Although the predictions matched with pharmacology in only 6/11 of cases, 3 novel compounds were found to induce an active-state secondary conformation. A CGP12177 derivative (methyl-pyrrole replacing the cyclic urea motif) retained catecholamine site antagonism with secondary site activation. Carteolol (related to CGP12177) and bunitrolol (similar to alprenolol) activated both conformations with biphasic concentration responses. Bunolol (CGP12177 derivative lacking nitrogen in the bicyclic system), as predicted, was a neutral antagonist with no secondary site activation. Moprolol and some bucindolol analogs appeared as conventional agonists, whereas other alprenolol and bucindolol analogs lost all receptor interaction. In a β1-adrenoceptor mutant (β1-V189T-L195Q-W199Y) where secondary site CGP12177 and pindolol interaction is lost, the 3 novel secondary-site compounds were also no longer able to stimulate secondary conformation responses, suggesting that there is a common TM4 secondary conformation-inducing interaction site. SIGNIFICANCE STATEMENT: The β1-adrenoceptor exists in 2 agonist-stabilized, pharmacologically distinguishable conformations. This study pinpointed the interaction site through which the alternative conformation is stabilized and suggested and evaluated additional ligands, thus providing possible molecular determinants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Adrenergic, beta-1Adrenergic beta-1 Receptor AgonistsHumansStructure-Activity RelationshipPropanolaminesLigandsAlprenololBinding SitesProtein ConformationCricetulusCHO CellsReceptors, Adrenergic, beta-2Animals

Stichwörter der Autor:innen

AffinityEfficacyMolecular modelingMolecular pharmacologySecondary siteβ1-adrenoceptor

Substanzen

Receptors, Adrenergic, beta-1PropanolaminesAdrenergic beta-1 Receptor AgonistsCGP 12177LigandsAlprenololbucindololReceptors, Adrenergic, beta-2

Autor:innen und Institutionen

  • Cell Signalling, School of Life Sciences, C Floor Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, UK; Respiratory Medicine, Sherwood Forest Hospitals NHS Trust, King's Mill Hospital, Nottin…
  • Philipps-Universität Marburg, Department of Pharmacy, Institute of Pharmaceutical Chemistry, Marburg, Germany.
  • Cell Signalling, School of Life Sciences, C Floor Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
  • Philipps-Universität Marburg, Department of Pharmacy, Institute of Pharmaceutical Chemistry, Marburg, Germany. Electronic address: peter.kolb@uni-marburg.de.

Förderung

  • German Research Foundation

Zitieren

APA

Baker, J. G., Lim, V. J. Y., Proudman, R. G. W., Giese, F. N. Z., & Kolb, P. (2025). Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100081

Vancouver

Baker JG, Lim VJY, Proudman RGW, Giese FNZ, Kolb P. Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100081

BibTeX
@article{Baker2025,
  author = {Baker, Jillian G and Lim, Victor Jun Yu and Proudman, Richard G W and Giese, Franziska N Z and Kolb, Peter},
  title = {Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor},
  journal = {Molecular Pharmacology},
  year = {2025},
  doi = {10.1016/j.molpha.2025.100081}
}
Kostenlos starten →